Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper.

Klimek, Ludger; Jutel, Marek; Bousquet, Jean; Agache, Ioana; Akdis, Cezmi; Hox, Valerie; Gevaert, Philippe; Tomazic, Peter; Rondon, Carmen; Cingi, CEMAL; Toppila-Salmi, Sanna; Karavelia, Aspasia; Bozkurt, Banu; Förster-Ruhrmann, Ulrike; Becker, Sven; Chaker, Adam; Wollenberg, Barbara; Mösges, Ralph; Huppertz, Tilman; Hagemann, Jan; Bachert, Claus; Fokkens, Wytske

doi:10.1111/all.14629

Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper.

Klimek L., Jutel M., Bousquet J., Agache I., Akdis C. A., Hox V., ...Daha Fazla

Allergy, cilt.76, ss.677-688, 2021 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 76
Basım Tarihi: 2021
Doi Numarası: 10.1111/all.14629
Dergi Adı: Allergy
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
Sayfa Sayıları: ss.677-688
Anahtar Kelimeler: biologics, chronic rhinosinusitis, COVID-19, CRSwNP, SARS-CoV-2, ENDOSCOPIC SINUS SURGERY, NASAL POLYPOSIS, ALLERGIC RHINITIS, GERMAN SOCIETY, ASTHMA, CORTICOSTEROIDS, EXACERBATIONS, ASSOCIATION, INTOLERANCE, PREVALENCE
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

BackgroundChronic rhinosinusitis is regarded as a chronic airway disease. According to WHO recommendations, it may be a risk factor for COVID-19 patients. In most CRSwNP cases, the inflammatory changes affecting the nasal and paranasal mucous membranes are type-2 (T2) inflammation endotypes.